The entire pharmaceutical
industry is governed by standards set by the FDA and other regulatory agencies.
Processes from drug discovery to commercial manufacturing, and everything in
between, are carefully observed and supervised. While these standards were not
directly apparent to me during my daily work, I was well aware of other
standards. My responsibilities as an intern were essentially a set of standards
that I was required to follow in order to best perform my job. I worked in an early-stage
cell culture group in the pre-clinical manufacturing and process development
division of Regeneron Pharmaceuticals. The cell culture group that I worked
with had developed a “speed to clinic” approach for evaluating drug candidates.
The process that we carried out on a daily basis was a set of numerous
standards that were combined together to create a “platform” process. This
process was carried each time project management gave us a new drug candidate
to evaluate. With each new drug candidate we were given data from protein
expression sciences. The data was a standard to which we expected the drug to
perform. We monitored nutrient levels and protein production for each drug
candidate and did our best to achieve results close to the original data. We
held weekly meetings were we discussed and observed various profiles for the
candidates. The two main profiles that we were interested in looking at were
titer (protein) and viable cell count. These two profiles became the standard
for us to observe. If we noticed anything unusual about either of these two
profiles, we would investigate other profiles to look for possible answers to
any abnormalities.
There were also many
standards within the laboratory. During the first week that I started working
at Regeneron, I underwent many training courses demonstrating common lab
practices. It was necessary for everyone to share common practices because
sterility is very important in dealing with biological specimens. Without
proper sterilization, cell culture will contaminate due to unwanted bacteria. I
learned sterile techniques for working in the hood, as well as, methods for
transferring cell culture from one vessel to another vessel while maintaining
sterility. We had a specific formula for making nutrient feed for the cells and
there was a well-defined set of standards for how this should be done. The
order in which the components were added and sterilizing the nutrient feed were
all things that needed to be taken into consideration. Setting up a production
bioreactor also had a set of standards associated with it. The head-plate of
each glass vessel contained various ports and lines that each had a different
function. Each person in the cell culture group followed the same protocol for
setting up a bioreactor. This was important because we all used the same
bioreactors for our experiments and we frequently helped perform each other’s
work.
The purpose of these
standards is to create an efficient “speed to clinic” process and to maintain a
laboratory environment that encourages proper sterile technique, as well as,
co-worker collaboration. Without these well-established standards in place, it
would have been ever difficult for me to perform my job and effectively help my
co-workers.
No comments:
Post a Comment